Want to join the conversation?
$ANIP said it got FDA approval of Prior Approval Supplement (PAS) for Oxcarbazepine Tablets, 150mg, 300mg and 600mg. Oxcarbazepine is antiepileptic drug indicated for use as monotherapy or adjunctive therapy in treatment of partial seizures in adults and as monotherapy in treatment of partial seizures in children aged 4 years & above with epilepsy.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?